ArticleJournal of neuroengineering and rehabilitation2026
Spinal cord neuromodulation for autonomic recovery following spinal cord injury: a scoping review.
Article in Journal of neuroengineering and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpinal cord injury (SCI) disrupts autonomic control, leading to cardiovascular, bowel, lower urinary tract (LUT), and sexual dysfunctions. Spinal cord stimulation (SCS) has shown therapeutic promise, but a comprehensive review of its effects on autonomic recovery after SCI has not been performed. PURPOSE: To synthesize evidence on the effects of SCS on autonomic functions, specifically cardiovascular, bowel, LUT, and sexual function, in animal models and individuals with SCI. DATA SOURCES: PubMed, EMBASE, and Web of Science; from date of inception to September 2025. STUDY SELECTION: Studies were included if they investigated the effects of SCS on cardiovascular, bowel, LUT, or sexual function in humans or animals with SCI. Of 2079 studies screened, 68 met inclusion criteria: 15 animals, 50 humans, and 3 involving both species. DATA EXTRACTION: Data were independently extracted, and final inclusion decisions were reached by consensus among authors. DATA SYNTHESIS: Both animal and human studies show that SCS enhances autonomic function after SCI. It improves bladder control, cardiovascular stability, and bowel motility in animals; and additionally alleviates neurogenic bowel symptoms, increases bladder capacity and compliance in humans. Improvements in sexual function were observed in both animal and human studies. LIMITATIONS: Evidence primarily comprises case reports, case series, and cohort studies, with few controlled trials. Mechanistic studies remain limited, and methodological heterogeneity restricts comparisons.
conclusionsSCS shows promise in improving autonomic dysfunction after SCI and enhancing quality of life. These findings inform priority areas for RCTs and mechanistic studies to optimize protocols and patient selection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.